MedPeer, Inc. (6095) AI Stock Analysis

• Market Cap: ¥15.30B
• Dividend Yield: 0.65%
• Average Volume (3M): 65.06K
• Price to Earnings (P/E): 10.1
• Beta (1Y): 0.93
• Revenue Growth: -17.86%
• EPS Growth: 133.08%
• Country: JP
• Employees: 489
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Healthcare Information Services
• EPS (TTM): 0.44
• Shares Outstanding: 22,010,330
• 10 Day Avg. Volume: 32,860
• 30 Day Avg. Volume: 65,060
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥768.00
• Price Target Upside: 10.50% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 0

• Rating: 71 Outperform
• Price Target: ¥768.00 ▲(10.50% Upside)

MedPeer, Inc. demonstrates strong financial performance with robust revenue and profit growth, which is the most significant factor in the overall score. The technical analysis indicates some bearish momentum, which slightly offsets the financial strengths. The valuation is reasonable, supporting the stock's attractiveness. The absence of earnings call and corporate events data did not impact the score.

MedPeer, Inc. Business Overview & Revenue Model

Company Description

MedPeer,Inc. provides services for doctors in Japan. The company operates and manages a web platform for doctors and medical students under the MedPeer name. It also provides online case consultation services; content services that allow to learn clinical knowledge that is useful to doctors in a quiz format; drug evaluation bulletin boards; and online lectures on clinical practices. In addition, the company operates an on-demand video channel centered on medical information under the name MedPeer Channel; MedPeer CAREER, a doctor-specialized recruiting information portal site; MedPeer CLINIC SUPPORT, a portal to check for properties related to opening clinics. The company was incorporated in 2004 and is based in Tokyo, Japan.

How the Company Makes Money

MedPeer, Inc. generates revenue through multiple channels, primarily focusing on subscription and advertising models. The company's platform offers premium subscription services to healthcare professionals who seek access to exclusive content, detailed medical case studies, and advanced networking tools. Additionally, MedPeer earns revenue from advertising by partnering with pharmaceutical companies and other healthcare-related businesses to promote products and services on their platform. These partnerships allow MedPeer to leverage its professional network to provide targeted advertising solutions. Furthermore, the company may generate income through sponsored content and collaborations with medical institutions for research and development projects.

MedPeer, Inc. Financial Statement Overview

Summary

MedPeer, Inc. exhibits solid financial performance with strong revenue and profit growth, efficient cost management, and low leverage. The income statement and balance sheet reflect overall financial health. However, cash flow management needs attention to support long-term growth and operational resilience.

Income Statement

MedPeer, Inc. demonstrates strong revenue growth with a notable increase from 2022 to TTM 2024. The gross profit margin is robust, indicating efficient cost management. While the net profit margin is healthy, the slight decline in EBIT margin suggests increasing operational expenses. Overall, the income statement reflects a solid financial performance with room for margin improvement.

Balance Sheet

The balance sheet is strong with a low debt-to-equity ratio, indicating financial stability and low leverage risk. The equity ratio highlights a solid asset base supported by equity. Return on Equity (ROE) is commendable, showing efficient use of shareholder funds. However, the slight increase in total liabilities requires monitoring to ensure continued financial health.

Cash Flow

Cash flow analysis shows mixed results. The operating cash flow has significantly increased, demonstrating enhanced cash-generating capability. Free cash flow has grown, but the absence of recent data limits a complete trend analysis. The ratio of operating cash flow to net income is favorable, suggesting good cash conversion. Continued focus on sustaining cash flow growth is necessary.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	13.41B	14.95B	14.54B	8.45B	7.44B	5.31B
Gross Profit	6.16B	6.87B	6.87B	5.03B	4.85B	3.51B
EBITDA	1.76B	3.01B	1.87B	1.30B	1.98B	1.27B
Net Income	1.71B	1.48B	617.68M	812.39M	1.29B	725.97M
Balance Sheet
Total Assets	14.81B	15.55B	15.16B	9.35B	8.54B	7.13B
Cash, Cash Equivalents and Short-Term Investments	7.16B	7.28B	5.39B	6.14B	5.70B	4.70B
Total Debt	2.90B	3.16B	3.81B	179.12M	136.32M	202.90M
Total Liabilities	5.02B	6.10B	6.57B	1.49B	1.56B	1.55B
Stockholders Equity	9.80B	9.45B	8.30B	7.59B	6.71B	5.35B
Cash Flow
Free Cash Flow	0.00	1.63B	494.10M	691.01M	1.11B	758.87M
Operating Cash Flow	0.00	1.89B	600.07M	853.23M	1.36B	930.30M
Investing Cash Flow	0.00	1.27B	-5.01B	-422.88M	-345.39M	-469.23M
Financing Cash Flow	0.00	-1.27B	3.67B	7.08M	-15.44M	1.11B

MedPeer, Inc. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 695.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6095, the sentiment is Negative. The current price of 695 is below the 20-day moving average (MA) of 696.00, below the 50-day MA of 708.10, and above the 200-day MA of 580.73, indicating a neutral trend. The MACD of -2.42 indicates Negative momentum. The RSI at 41.19 is Neutral, neither overbought nor oversold. The STOCH value of 50.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:6095.

MedPeer, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
3649	79 Outperform	22.82B	19.91	―	1.80%	-6.29%	-22.25%
4320	73 Outperform	13.12B	12.47	2.02%	2.31%	7.79%	38592.95%
3939	72 Outperform	23.14B	22.75	23.99%	1.33%	13.39%	12.00%
6095	71 Outperform	¥15.30B	10.14	―	0.65%	-17.86%	133.08%
4263	45 Neutral	14.40B	-48.14	―	―	35.15%	16.89%
3902	43 Neutral	23.55B	-32.19	―	1.08%	-0.58%	-260.22%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

MedPeer, Inc. Corporate Events

MedPeer, Inc. Announces Treasury Share Cancellation

MedPeer, Inc. has announced a resolution to cancel 311,521 of its treasury shares, which constitutes 1.42% of the total issued shares, pending approval at an extraordinary shareholders meeting. This move is part of a broader strategy involving share consolidation and amendments to the company’s articles of incorporation, potentially impacting the company’s capital structure and shareholder value.

The most recent analyst rating on (JP:6095) stock is a Hold with a Yen762.00 price target. To see the full list of analyst forecasts on MedPeer, Inc. stock, see the JP:6095 Stock Forecast page.

MedPeer, Inc. Announces Shareholder Meeting for Strategic Changes and Delisting

MedPeer, Inc. has announced an extraordinary general meeting of shareholders to discuss significant changes including share consolidation, amendments to the articles of incorporation, and a reduction in stated capital. These changes will lead to the company’s delisting from the Tokyo Stock Exchange, marking a significant shift in its market presence and operations. The move is part of a management buyout strategy, with the aim of privatizing the company and involving key stakeholders in its future direction.

The most recent analyst rating on (JP:6095) stock is a Hold with a Yen762.00 price target. To see the full list of analyst forecasts on MedPeer, Inc. stock, see the JP:6095 Stock Forecast page.

MedPeer, Inc. Announces Capital Reduction Plan

MedPeer, Inc. announced a capital reduction plan, approved by its Board of Directors, to be presented at the upcoming extraordinary general meeting of shareholders. The reduction aims to maintain financial health and ensure a flexible capital policy without affecting the number of shares or net assets per share.

MedPeer, Inc. Reports Decline in Nine-Month Financial Results

MedPeer, Inc. reported a decline in its consolidated financial results for the nine months ended June 30, 2025, with net sales dropping by 20.8% and operating profit decreasing by 27.6% compared to the previous year. Despite the financial challenges, the company maintained a stable equity-to-asset ratio and announced no revisions to its earnings forecasts, indicating a cautious yet steady approach to its financial strategy.

MedPeer Sets Record Date for Extraordinary Shareholders Meeting

MedPeer, Inc. has announced the setting of a record date for an upcoming Extraordinary General Meeting of Shareholders, scheduled between late September and early October 2025. This meeting follows a successful tender offer by NMT, Inc., although not all shares were acquired. The agenda includes proposals for share consolidation and amendments to the articles of incorporation, which could impact shareholder structure and governance.

MedPeer, Inc. Announces Change in Parent Company Following Successful Tender Offer

MedPeer, Inc. has announced the successful conclusion of a tender offer by NMT, Inc. for its common shares and stock acquisition rights, which began on May 15, 2025. As a result of the tender offer, NMT, Inc. will become the new parent company and largest major shareholder of MedPeer, Inc., with more than 50% of the voting rights, effective August 15, 2025. This change in ownership is expected to impact the company’s operations and market positioning.

MedPeer, Inc. Announces Amendments to MBO and Tender Offer Recommendations

MedPeer, Inc. has announced amendments to its previously issued notices regarding a Management Buyout (MBO) and a recommendation to tender shares. The company has resolved to support the tender offer initiated by NMT, Inc., which includes extending the tender offer period to provide shareholders with more time to decide. This decision is aimed at enhancing corporate value and ensuring fairness in the transaction, reflecting MedPeer’s commitment to its shareholders and corporate governance.

MedPeer Extends Tender Offer Period Amid Stable Share Price

MedPeer, Inc. announced an extension of the tender offer period by NMT, Inc. for its share certificates, now totaling 60 business days. The tender offer price remains unchanged at 700 yen per share, and no insider information affecting investor decisions has been reported. The settlement date is set for August 15, 2025, and the company has clarified that shares not tendered will be acquired by the Tender Offeror if the offer is successful.

MedPeer, Inc. Announces Extension of NMT, Inc.’s Tender Offer

MedPeer, Inc. has announced an amendment to the ongoing tender offer by NMT, Inc. for its shares. The tender offer, which began on May 15, 2025, has been extended to August 7, 2025, to provide shareholders more time to consider their participation. This extension aims to increase the likelihood of completing the tender offer, impacting MedPeer’s shareholder dynamics and potentially its market positioning.

MedPeer, Inc. Announces Extension of NMT, Inc.’s Tender Offer Period

MedPeer, Inc. has announced an amendment to the ongoing tender offer by NMT, Inc. for its share certificates. The tender offer period has been extended by 10 business days, now concluding on July 24, 2025, to provide shareholders additional time to consider their options. This move aims to enhance the likelihood of the tender offer’s completion, reflecting a strategic effort by NMT, Inc. to secure its acquisition of MedPeer, Inc.